576 related articles for article (PubMed ID: 19195605)
1. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
[TBL] [Abstract][Full Text] [Related]
3. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
[TBL] [Abstract][Full Text] [Related]
4. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
[TBL] [Abstract][Full Text] [Related]
6. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
7. Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up.
Verhaert D; Grimm RA; Puntawangkoon C; Wolski K; De S; Wilkoff BL; Starling RC; Tang WH; Thomas JD; Popović ZB
J Am Coll Cardiol; 2010 Apr; 55(17):1788-95. PubMed ID: 20413027
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
[TBL] [Abstract][Full Text] [Related]
9. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.
Zhang Q; Fung JW; Auricchio A; Chan JY; Kum LC; Wu LW; Yu CM
Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380
[TBL] [Abstract][Full Text] [Related]
10. Recoordination rather than resynchronization predicts reverse remodeling after cardiac resynchronization therapy.
Wang CL; Wu CT; Yeh YH; Wu LS; Chang CJ; Ho WJ; Hsu LA; Luqman N; Kuo CT
J Am Soc Echocardiogr; 2010 Jun; 23(6):611-20. PubMed ID: 20418055
[TBL] [Abstract][Full Text] [Related]
11. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
[TBL] [Abstract][Full Text] [Related]
12. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of renal function in patients with cardiac resynchronization therapy.
Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
[TBL] [Abstract][Full Text] [Related]
14. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
[TBL] [Abstract][Full Text] [Related]
15. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.
Bertini M; Delgado V; Nucifora G; Marsan NA; Ng AC; Shanks M; Van Bommel RJ; Borleffs CJ; Ewe SH; Boriani G; Biffi M; Schalij MJ; Bax JJ
Am J Cardiol; 2010 Sep; 106(5):682-7. PubMed ID: 20723646
[TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
17. Effect of cardiac resynchronization therapy on left ventricular diastolic filling pattern in responder and nonresponder patients.
Agacdiken A; Vural A; Ural D; Sahin T; Kozdag G; Kahraman G; Bildirici U; Ural E; Komsuoglu B
Pacing Clin Electrophysiol; 2005 Jul; 28(7):654-60. PubMed ID: 16008800
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale.
Muto C; Gasparini M; Iacopino S; Peraldo C; Curnis A; Sassone B; Diotallevi P; Davinelli M; Valsecchi S; Tuccillo B
Am Heart J; 2008 Oct; 156(4):656-61. PubMed ID: 18926147
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
